Accordingly, we selected the Bcl3 promoter as our experimental model among the 14 SP1-enriched, G4-containing candidates, based on its high G4-forming potential (G-score = 42; ranked 3rd) and its established relevance to breast cancer [36, 42]. Here, BCL3 is linked to breast carcinoma.